{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:09:54Z","timestamp":1787659794927,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s13300-025-01788-7","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T09:49:39Z","timestamp":1758016179000},"page":"2123-2136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence, Demographic and Clinical Characteristics of Individuals with Early Onset Type 2 Diabetes in the USA: an NHANES Analysis 1999\u20132020"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-0207","authenticated-orcid":false,"given":"Clare J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3668-7686","authenticated-orcid":false,"given":"Brandon K.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4261-8123","authenticated-orcid":false,"given":"Ray","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2461-1919","authenticated-orcid":false,"given":"Suzanne","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5953-5929","authenticated-orcid":false,"given":"Kristina S.","family":"Boye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"issue":"3","key":"1788_CR1","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s12020-024-03772-w","volume":"85","author":"M Strati","year":"2024","unstructured":"Strati M, Moustaki M, Psaltopoulou T, Vryonidou A, Paschou SA. Early onset type 2 diabetes mellitus: an update. Endocrine. 2024;85(3):965\u201378. https:\/\/doi.org\/10.1007\/s12020-024-03772-w.","journal-title":"Endocrine"},{"issue":"3","key":"1788_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2337\/diacare.28.3.638","volume":"28","author":"N Gungor","year":"2005","unstructured":"Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: insulin resistance, \u03b2-cell failure, or both? Diabetes Care. 2005;28(3):638\u201344. https:\/\/doi.org\/10.2337\/diacare.28.3.638.","journal-title":"Diabetes Care"},{"issue":"1","key":"1788_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-8587(17)30186-9","volume":"6","author":"N Lascar","year":"2018","unstructured":"Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69\u201380. https:\/\/doi.org\/10.1016\/S2213-8587(17)30186-9.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1788_CR4","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2337\/dc12-2393","volume":"36","author":"TODAY Study Group","year":"2013","unstructured":"TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and \u03b2-cell function in TODAY. Diabetes Care. 2013;36(6):1749\u201357. https:\/\/doi.org\/10.2337\/dc12-2393.","journal-title":"Diabetes Care"},{"issue":"9","key":"1788_CR5","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.2337\/dc19-0556","volume":"42","author":"RISE Consortium","year":"2019","unstructured":"RISE Consortium. Lack of durable improvements in \u03b2-cell function following withdrawal of pharmacological interventions in adults with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care. 2019;42(9):1742\u201351. https:\/\/doi.org\/10.2337\/dc19-0556.","journal-title":"Diabetes Care"},{"issue":"8","key":"1788_CR6","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2337\/dc18-0787","volume":"41","author":"RISE Consortium","year":"2018","unstructured":"RISE Consortium. Impact of insulin and metformin versus metformin alone on \u03b2-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care. 2018;41(8):1717\u201325. https:\/\/doi.org\/10.2337\/dc18-0787.","journal-title":"Diabetes Care"},{"issue":"8","key":"1788_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2017.0686","volume":"317","author":"D Dabelea","year":"2017","unstructured":"Dabelea D, Stafford JM, Mayer-Davis EJ, et al. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA. 2017;317(8):825\u201335. https:\/\/doi.org\/10.1001\/jama.2017.0686.","journal-title":"JAMA"},{"issue":"5","key":"1788_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2337\/dc15-0991","volume":"39","author":"AH Al-Saeed","year":"2016","unstructured":"Al-Saeed AH, Constantino MI, Molyneaux L, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care. 2016;39(5):823\u20139. https:\/\/doi.org\/10.2337\/dc15-0991.","journal-title":"Diabetes Care"},{"issue":"6","key":"1788_CR9","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.2337\/dc12-2420","volume":"36","author":"TODAY Study Group","year":"2013","unstructured":"TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36(6):1735\u201341. https:\/\/doi.org\/10.2337\/dc12-2420.","journal-title":"Diabetes Care"},{"issue":"15","key":"1788_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","volume":"376","author":"EJ Mayer-Davis","year":"2017","unstructured":"Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. SEARCH for Diabetes in Youth Study. Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012. N Engl J Med. 2017;376(15):1419\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1610187.","journal-title":"N Engl J Med"},{"issue":"6","key":"1788_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/2040622314548679","volume":"5","author":"E Wilmot","year":"2014","unstructured":"Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis. 2014;5(6):234\u201344. https:\/\/doi.org\/10.1177\/2040622314548679.","journal-title":"Ther Adv Chronic Dis"},{"issue":"2","key":"1788_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1399-5448.2012.00915.x","volume":"14","author":"F Bacha","year":"2013","unstructured":"Bacha F, Gungor N, Lee S, Arslanian SA. Progressive deterioration of \u03b2-cell function in obese youth with type 2 diabetes. Pediatr Diabetes. 2013;14(2):106\u201311. https:\/\/doi.org\/10.1111\/j.1399-5448.2012.00915.x.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"1788_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11892-012-0341-0","volume":"13","author":"M Cree-Green","year":"2013","unstructured":"Cree-Green M, Triolo TM, Nadeau KJ. Etiology of insulin resistance in youth with type 2 diabetes. Curr Diab Rep. 2013;13(1):81\u20138. https:\/\/doi.org\/10.1007\/s11892-012-0341-0.","journal-title":"Curr Diab Rep"},{"key":"1788_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072385","volume":"379","author":"J Xie","year":"2022","unstructured":"Xie J, Wang M, Long Z, et al. Global burden of type 2 diabetes in adolescents and young adults, 1990\u20132019: systematic analysis of Global Burden of Disease Study 2019. BMJ. 2022;379: e072385. https:\/\/doi.org\/10.1136\/bmj-2022-072385.","journal-title":"BMJ"},{"key":"1788_CR15","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey (NHANES) Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2022. Available at: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/Default.aspx. Accessed 1 Apr 2025."},{"key":"#cr-split#-1788_CR16.1","unstructured":"Zipf G, Chiappa M, Porter KS, et al. National Health and Nutrition Examination Survey: plan and operations, 1999-2010. National Center for Health Statistics (NCHS). Vital and Health Stat. 2013"},{"key":"#cr-split#-1788_CR16.2","unstructured":"1(56): 1-37. https:\/\/www.cdc.gov\/nchs\/data\/series\/sr_01\/sr01_056.pdf. Accessed 1 Apr 2025."},{"issue":"10","key":"1788_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","volume":"20","author":"ND Wong","year":"2023","unstructured":"Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685\u201395. https:\/\/doi.org\/10.1038\/s41569-023-00877-z.","journal-title":"Nat Rev Cardiol"},{"key":"1788_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-024-01980-8","author":"NC Manfouo Fouotsa","year":"2024","unstructured":"Manfouo Fouotsa NC, Ndjaboue R, Ngueata G. Race\/ethnicity and other predictors of early-onset type 2 diabetes mellitus in the US population. J Racial Ethn Health Disparities. 2024. https:\/\/doi.org\/10.1007\/s40615-024-01980-8. (Online ahead of print).","journal-title":"J Racial Ethn Health Disparities"},{"issue":"3","key":"1788_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2337\/dc24-1699","volume":"48","author":"L Xu","year":"2025","unstructured":"Xu L, Ran J, Shao H, et al. Incidence and risk factors of diagnosed young-adult-onset type 2 diabetes in the US: the National Health Interview Survey 2016\u20132022. Diabetes Care. 2025;48(3):371\u201380. https:\/\/doi.org\/10.2337\/dc24-1699.","journal-title":"Diabetes Care"},{"issue":"10105","key":"1788_CR20","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(17)32461-3","volume":"390","author":"J McGavock","year":"2017","unstructured":"McGavock J, Wicklow B, Dart AB. Type 2 diabetes in youth is a disease of poverty. Lancet. 2017;390(10105):1829. https:\/\/doi.org\/10.1016\/S0140-6736(17)32461-3.","journal-title":"Lancet"},{"issue":"1","key":"1788_CR21","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1186\/s12889-023-17280-5","volume":"23","author":"M Wang","year":"2023","unstructured":"Wang M, He Y, He Q, et al. Comparison of clinical characteristics and disease burden between early- and late-onset type 2 diabetes patients: a populations-based cohort study. BMC Public Health. 2023;23(1):2411. https:\/\/doi.org\/10.1186\/s12889-023-17280-5.","journal-title":"BMC Public Health"},{"issue":"6","key":"1788_CR22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.2337\/dc23-2356","volume":"47","author":"P Zeitler","year":"2024","unstructured":"Zeitler P, Galindo RJ, Davies MJ, et al. Early-onset type 2 diabetes and tirzepatide treatment: a post hoc analysis from the SURPASS clinical trial program. Diabetes Care. 2024;47(6):1056\u201364. https:\/\/doi.org\/10.2337\/dc23-2356.","journal-title":"Diabetes Care"},{"issue":"6","key":"1788_CR23","first-page":"585","volume":"100","author":"RC Lagan","year":"2024","unstructured":"Lagan RC, Hines-Smith KA. Mildly elevated liver transaminase levels: causes and evaluation. Am Fam Physician. 2024;100(6):585\u201391 (PMID: 39700361).","journal-title":"Am Fam Physician"},{"issue":"4","key":"1788_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1067\/S0022-3476(03)00325-1","volume":"143","author":"JB Schwimmer","year":"2003","unstructured":"Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143(4):500\u20135. https:\/\/doi.org\/10.1067\/S0022-3476(03)00325-1.","journal-title":"J Pediatr"},{"issue":"10","key":"1788_CR25","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","volume":"18","author":"F Baratta","year":"2020","unstructured":"Baratta F, Pastori D, Angelico F, et al. Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study. Clin Gastroenterol Hepatol. 2020;18(10):2324\u201331. https:\/\/doi.org\/10.1016\/j.cgh.2019.12.026. (e4).","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1788_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/dc17-1902","volume":"41","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Byrne CD, Bonora E, Targher G. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care. 2018;41(2):372\u201382. https:\/\/doi.org\/10.2337\/dc17-1902.","journal-title":"Diabetes Care"},{"issue":"2","key":"1788_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4254\/wjh.v9.i2.69","volume":"9","author":"A Di Sessa","year":"2017","unstructured":"Di Sessa A, Umano GR, Miraglia Del Giudice E, Santoro N. From the liver to the heart: cardiac dysfunction in obese children with non-alcoholic fatty liver disease. World J Hepatol. 2017;9(2):69\u201373. https:\/\/doi.org\/10.4254\/wjh.v9.i2.69.","journal-title":"World J Hepatol"},{"issue":"19","key":"1788_CR28","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","volume":"139","author":"N Sattar","year":"2019","unstructured":"Sattar N, Rawshani A, Franz\u00e9n S, et al. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation. 2019;139(19):2228\u201337. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037885.","journal-title":"Circulation"},{"issue":"1","key":"1788_CR29","doi-asserted-by":"publisher","first-page":"29155","DOI":"10.1038\/s41598-024-80790-8","volume":"14","author":"HJ Zhang","year":"2024","unstructured":"Zhang HJ, Feng J, Zhang XT, Zhang HZ. Age at type 2 diabetes diagnosis and the risk of mortality among US population. Sci Rep. 2024;14(1):29155. https:\/\/doi.org\/10.1038\/s41598-024-80790-8.","journal-title":"Sci Rep"},{"key":"1788_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109129","volume":"182","author":"F-S Yen","year":"2021","unstructured":"Yen F-S, Lo Y-R, Hwu C-M, Hsu C-C. Early-onset type 2 diabetes <60 years and risk of vascular complications. Diabetes Res Clin Pract. 2021;182: 109129. https:\/\/doi.org\/10.1016\/j.diabres.2021.109129.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1788_CR31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/jdi.13763","volume":"13","author":"L Huang","year":"2022","unstructured":"Huang L, Wu P, Zhang Y, et al. Relationship between onset age of type 2 diabetes mellitus and vascular complications based on propensity score matching analysis. J Diabetes Investig. 2022;13(6):1062\u201372. https:\/\/doi.org\/10.1111\/jdi.13763.","journal-title":"J Diabetes Investig"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01788-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:10:00Z","timestamp":1761948600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01788-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01788-7","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clare J. Lee, Brandon K. Bergman, Ray Gou and Kristina S. Boye are full-time employees and minor stockholders of Eli Lilly and Company. Suzanne Williamson works as a consultant for Eli Lilly and Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This was a secondary research study conducted using data from the publicly available deidentified NHANES database; therefore, neither institutional review board review nor formal participant consent to release (or publish) information was required. Ethical approval for the NHANES study was obtained from the NCHS Research Ethics Review Board (NHANES\u2013NCHS Research Ethics Review Board Approval;\n                      \n                      ). No additional ethical consent was necessary for the secondary data analyses in this study. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}